Wells Fargo & Company: Form 10-Q for the period ended Jun 30, 2026
Filed with the SEC on Jul 28, 2026 and accepted by EDGAR at Jul 28, 2026, 16:46 ET.
Management's discussion and analysis
As filed, 779 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following table shows Company repurchases of its common stock for each calendar month in the quarter ended June 30, 2026.
| Calendar month | Total number of shares repurchased (1) | Weighted average price paid per share | Approximate dollar value of shares that may yet be repurchased under the authorization (in millions) |
|---|---|---|---|
| April | 23,944,446 | $81.14 | $23,815 |
| May | 880,346 | 82.00 | 23,743 |
| June | 12,530,780 | 79.80 | 22,743 |
| Total | 37,355,572 |
(1) All shares were repurchased under an authorization covering up to $40 billion of common stock approved by the Board of Directors (Board) and publicly announced by the Company on April 29, 2025. Unless modified or revoked by the Board, this authorization does not expire.
Risk factors
As filed, 179 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Information in response to this item can be found under the “Financial Review – Risk Factors” section in this Report which information is incorporated by reference into this item.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2026-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2026-04-01 to 2026-06-30 | $22.62bn | us-gaap:RevenuesNetOfInterestExpense |
| Revenue | 6 months2026-01-01 to 2026-06-30 | $44.07bn | us-gaap:RevenuesNetOfInterestExpense |
| Income tax | 3 months2026-04-01 to 2026-06-30 | $1.40bn | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2026-01-01 to 2026-06-30 | $2.09bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2026-04-01 to 2026-06-30 | $6.41bn | us-gaap:NetIncomeLoss |
| Net income | 6 months2026-01-01 to 2026-06-30 | $11.66bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2026-04-01 to 2026-06-30 | $2.00 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2026-01-01 to 2026-06-30 | $3.60 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2026-04-01 to 2026-06-30 | $2.02 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2026-01-01 to 2026-06-30 | $3.64 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2026-04-01 to 2026-06-30 | 3,074,600,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2026-01-01 to 2026-06-30 | 3,096,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2026-01-01 to 2026-06-30 | $15.92bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 6 months2026-01-01 to 2026-06-30 | $2.75bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2026-01-01 to 2026-06-30 | $7.01bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Total assets | At period end2026-06-30 | $2.28tn | us-gaap:Assets |
| Total liabilities | At period end2026-06-30 | $2.10tn | us-gaap:Liabilities |
| Long-term debt | At period end2026-06-30 | $182.14bn | us-gaap:LongTermDebt |
| Short-term borrowings | At period end2026-06-30 | $25.17bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2026-06-30 | $180.19bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000072971-26-000302. Last ingested by Listed: Nov 14, 2026, 15:33 ET. Listed shows no prices and gives no investment advice.